ANI Pharmaceuticals

An emerging leader in the specialty pharmaceuticals industry, ANI Pharmaceuticals (Nasdaq: ANIP) develops, manufactures, and markets top-quality prescription pharmaceuticals. In two facilities with combined manufacturing, packaging, and laboratory capacity exceeding 170,000 sq. ft., ANI develops and manufactures liquid, powder, and oral solid dose products, including those requiring containment. ANI also performs contract manufacturing for some of the largest and most respected pharmaceutical companies in the world. ANI has several ANDAs pending FDA approval and in various stages of development.